Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
- Update frequency
- every 5 days
- Episodes
- 347
- Years Active
- 2015 - 2025
Exploring Advances in Treatment: A Step Forward in Small Cell Lung Cancer
Guest: Millie Das, MD
What are some of the latest advancements in small cell lung cancer? Dr. Jacob Sands discusses small-cell lung cancer treatment developments w…
Investigating Immunotherapy & Its Role in NSCLC
Guest: Mark Awad, MD, PhD
Immunotherapy has led to impressive results, but when is it needed? Dr. Jacob Sands discusses the role of immunotherapy in managing lung …
Evaluating Biomarkers at Work in NSCLC
Guest: Mark Awad, MD, PhD
What do we need to know about the role of biomarkers in non-small cell lung cancer? Dr. Mark Awad from the Dana-Farber Cancer Institute e…
Investigating Immunotherapy & Its Role in NSCLC
Guest: Mark Awad, MD, PhD
Immunotherapy has led to impressive results, but when is it needed? Dr. Jacob Sands discusses the role of immunotherapy in managing lung …
Evaluating Biomarkers at Work in NSCLC
Guest: Mark Awad, MD, PhD
What do we need to know about the role of biomarkers in non-small cell lung cancer? Dr. Mark Awad from the Dana-Farber Cancer Institute e…
Reacting to RET Inhibitors: A Look at Progression & the Future
After starting on a RET inhibitor, what do you do? Dr. Ross Camidge, the Director of the Thoracic Oncology Clinical and Clinical Research Programs at the Uni…
Concerning Kinases: Therapeutic Considerations for RET Rearranged NSCLC
With only two targeted therapy options available for RET rearranged advanced non-small cell lung cancer, how do we select the best approach? Dr. Ross Camidge…
Reacting to RET Inhibitors: A Look at Progression & the Future
After starting on a RET inhibitor, what do you do? Dr. Ross Camidge, the Director of the Thoracic Oncology Clinical and Clinical Research Programs at the Uni…
Concerning Kinases: Therapeutic Considerations for RET Rearranged NSCLC
With only two targeted therapy options available for RET rearranged advanced non-small cell lung cancer, how do we select the best approach? Dr. Ross Camidge…
ASCO Investigates Disparities in Cancer Care: Representation in Oncology
Guest: Lori Pierce, MD, FASTRO, FASCO
With only 3% of practicing oncologists identifying as Black, and less than 5% identifying as Latinx, how can we ensure these …
ASCO Investigates Disparities in Cancer Care: Representation in Oncology
Guest: Lori Pierce, MD, FASTRO, FASCO
With only 3% of practicing oncologists identifying as Black, and less than 5% identifying as Latinx, how can we ensure these …
Assessing Quality of Care: Implementing a Lung Screening Program
Guest: Andrea B. McKee, MD
How can a lung screening program enhance the quality of care for patients with lung cancer? Dr. Andrea McKee, Chair Emeritus in Radiatio…
Assessing Quality of Care: Implementing a Lung Screening Program
Guest: Andrea B. McKee, MD
How can a lung screening program enhance the quality of care for patients with lung cancer? Dr. Andrea McKee, Chair Emeritus in Radiatio…
Understanding Updates in Lung Cancer Screening
Guest: Andrea B. McKee, MD
Lung cancer screening is one of the most critical components of reducing cancer mortality rates. Dr. Andrea McKee, Chair Emeritus in Rad…
Understanding Updates in Lung Cancer Screening
Guest: Andrea B. McKee, MD
Lung cancer screening is one of the most critical components of reducing cancer mortality rates. Dr. Andrea McKee, Chair Emeritus in Rad…
Exploring Early-Stage Mesothelioma: What Are the Latest Treatment Approaches?
Guest: Aaron S. Mansfield, MD
There are different treatment options available for early-stage mesothelioma, and there seem to be differences in standard practice f…
Exploring Early-Stage Mesothelioma: What Are the Latest Treatment Approaches?
Guest: Aaron S. Mansfield, MD
There are different treatment options available for early-stage mesothelioma, and there seem to be differences in standard practice f…
A Step-by-Step Approach to Managing Mesothelioma
Guest: Aaron S. Mansfield, MD
Mesothelioma is a cancer with limited treatment options, so how can we manage it in the first and second-line settings and beyond? He…
A Step-by-Step Approach to Managing Mesothelioma
Guest: Aaron S. Mansfield, MD
Mesothelioma is a cancer with limited treatment options, so how can we manage it in the first and second-line settings and beyond? He…
Exploring EGFR Mutations in Lung Cancer: Key Diagnostic & Management Strategies
Guest: Pasi Antero Jänne, MD, PhD
Once we’ve confirmed a patient has EGFR-mutated lung cancer, how can we treat them? Joining Dr. Jacob Sands to discuss the curren…